人乳头瘤病毒疫苗将如何影响宫颈癌？
How will HPV vaccines affect cervical cancer?
作者信息
Roden Richard, Wu T-C
机构信息
Department of Pathology, The Johns Hopkins University, Baltimore, Maryland 21231, USA.
出版信息
Nat Rev Cancer. 2006 Oct;6(10):753-63. doi: 10.1038/nrc1973.
Abstract
Cancer of the uterine cervix is the second largest cause of cancer deaths in women, and its toll is greatest in populations that lack screening programmes to detect precursor lesions. Persistent infection with 'high risk' genotypes of human papillomavirus (HPV) is necessary, although not sufficient, to cause cervical carcinoma. Therefore, HPV vaccination provides an opportunity to profoundly affect cervical cancer incidence worldwide. A recently licensed HPV subunit vaccine protects women from a high proportion of precursor lesions of cervical carcinoma and most genital warts. Here we examine the ramifications and remaining questions that surround preventive HPV vaccines.
摘要
子宫颈癌是女性癌症死亡的第二大原因，在缺乏检测癌前病变筛查计划的人群中，其造成的死亡人数最多。人乳头瘤病毒（HPV）“高危”基因型的持续感染是导致宫颈癌的必要条件，尽管并非充分条件。因此，HPV疫苗接种为深刻影响全球宫颈癌发病率提供了一个契机。一种最近获得许可的HPV亚单位疫苗可使女性预防大部分宫颈癌前病变和大多数尖锐湿疣。在此，我们探讨围绕预防性HPV疫苗的影响及尚存的问题。
相似文献
1
How will HPV vaccines affect cervical cancer?人乳头瘤病毒疫苗将如何影响宫颈癌？
Nat Rev Cancer. 2006 Oct;6(10):753-63. doi: 10.1038/nrc1973.
2
[Human papillomavirus prophylactic vaccines: stakes and perspectives].[人乳头瘤病毒预防性疫苗：风险与前景]
Gynecol Obstet Fertil. 2006 Jul-Aug;34(7-8):647-55. doi: 10.1016/j.gyobfe.2006.05.008. Epub 2006 Jun 27.
3
Preventive and therapeutic HPV vaccines.预防性和治疗性人乳头瘤病毒疫苗
Curr Opin Investig Drugs. 2007 Dec;8(12):1038-50.
4
Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).四价人乳头瘤病毒疫苗：免疫实践咨询委员会（ACIP）的建议
MMWR Recomm Rep. 2007 Mar 23;56(RR-2):1-24.
5
[Cervical cancer prevention: the impact of HPV vaccination].宫颈癌预防：人乳头瘤病毒疫苗的影响
Gynecol Obstet Fertil. 2006 Mar;34(3):189-201. doi: 10.1016/j.gyobfe.2006.01.036. Epub 2006 Mar 10.
6
Vaccines against human papillomavirus and cervical cancer: promises and challenges.针对人乳头瘤病毒和宫颈癌的疫苗：前景与挑战
Oncologist. 2005 Aug;10(7):528-38. doi: 10.1634/theoncologist.10-7-528.
7
Prevention strategies of cervical cancer in the HPV vaccine era.人乳头瘤病毒疫苗时代的宫颈癌预防策略
Gynecol Oncol. 2006 Oct;103(1):21-4. doi: 10.1016/j.ygyno.2006.07.019. Epub 2006 Aug 17.
8
Papillomavirus-like particle vaccines for cervical cancer.用于宫颈癌的乳头瘤病毒样颗粒疫苗。
Mol Med Today. 1999 May;5(5):209-15. doi: 10.1016/S1357-4310(99)01463-X.
9
Human papillomavirus infection: an old disease, a new vaccine.人乳头瘤病毒感染：一种古老的疾病，一种新型疫苗。
Aust N Z J Obstet Gynaecol. 2006 Jun;46(3):180-5. doi: 10.1111/j.1479-828X.2006.00580.x.
10
[Vaccination against human papillomavirus for the prevention of cervical cancer].[接种人乳头瘤病毒疫苗预防宫颈癌]
Ned Tijdschr Geneeskd. 2006 Jun 24;150(25):1380-4.
引用本文的文献
1
Human papilloma virus (HPV) mediated cancers: an insightful update.人乳头瘤病毒（HPV）介导的癌症：深入的最新进展
J Transl Med. 2025 Apr 29;23(1):483. doi: 10.1186/s12967-025-06470-x.
2
Prophylactic vaccines against HPV-caused cervical cancer: novel vaccines are still demanded.针对人乳头瘤病毒（HPV）引发的宫颈癌的预防性疫苗：仍需要新型疫苗。
Infect Agent Cancer. 2025 Mar 10;20(1):16. doi: 10.1186/s13027-025-00643-5.
3
Designing and immunomolecular analysis of a new broad-spectrum multiepitope vaccine against divergent human papillomavirus types.针对多种不同人类乳头瘤病毒类型的新型广谱多表位疫苗的设计及免疫分子分析
PLoS One. 2024 Dec 2;19(12):e0311351. doi: 10.1371/journal.pone.0311351. eCollection 2024.
4
An Injection Molded SlipChip with Self-Sampling for Integrated Point-of-Care Testing of Human Papilloma Virus.一种注塑成型的 slipChip，具有自采样功能，用于在现场即时检测人乳头瘤病毒。
Adv Sci (Weinh). 2024 Nov;11(43):e2406367. doi: 10.1002/advs.202406367. Epub 2024 Sep 25.
5
Cancer immunotherapy and its facilitation by nanomedicine.癌症免疫疗法及其纳米医学促进作用。
Biomark Res. 2024 Aug 3;12(1):77. doi: 10.1186/s40364-024-00625-6.
6
Vaccination with a Human Papillomavirus L2 Multimer Provides Broad Protection against 17 Human Papillomavirus Types in the Mouse Cervicovaginal Challenge Model.用人乳头瘤病毒L2多聚体进行疫苗接种可在小鼠宫颈阴道攻击模型中对17种人乳头瘤病毒类型提供广泛保护。
Vaccines (Basel). 2024 Jun 20;12(6):689. doi: 10.3390/vaccines12060689.
7
High-Risk Genotypes of Human Papillomavirus at Diverse Anogenital Sites among Chinese Women: Infection Features and Potential Correlation with Cervical Intraepithelial Neoplasia.中国女性不同肛门生殖器部位人乳头瘤病毒的高危基因型：感染特征及与宫颈上皮内瘤变的潜在相关性
Cancers (Basel). 2024 May 31;16(11):2107. doi: 10.3390/cancers16112107.
8
Drug-containing Serum of Quyoufang Promotes Apoptosis of Ectocervical H8 Cells through an E6/p53-related Pathway.祛疣方含药血清通过E6/p53相关途径促进宫颈外H8细胞凋亡。
Comb Chem High Throughput Screen. 2025;28(1):122-131. doi: 10.2174/0113862073263350231107105959.
9
Effectiveness of combination therapy with ISA101 vaccine for the treatment of human papillomavirus-induced cervical cancer.ISA101疫苗联合疗法治疗人乳头瘤病毒引发的宫颈癌的有效性
Front Oncol. 2022 Oct 10;12:990877. doi: 10.3389/fonc.2022.990877. eCollection 2022.
10
High Prevalence of HPV 51 in an Unvaccinated Population and Implications for HPV Vaccines.未接种疫苗人群中HPV 51的高流行率及其对HPV疫苗的启示
Vaccines (Basel). 2022 Oct 20;10(10):1754. doi: 10.3390/vaccines10101754.
本文引用的文献
1
IMMUNIZATION OF RABBITS TO INFECTIOUS PAPILLOMATOSIS.兔传染性乳头状瘤病的免疫接种。
J Exp Med. 1937 Jan 31;65(2):219-31. doi: 10.1084/jem.65.2.219.
2
THE PROGRESSION TO CARCINOMA OF VIRUS-INDUCED RABBIT PAPILLOMAS (SHOPE).病毒诱导的兔乳头瘤（绍普）癌的进展
J Exp Med. 1935 Sep 30;62(4):523-48. doi: 10.1084/jem.62.4.523.
3
Condom use and the risk of genital human papillomavirus infection in young women.年轻女性使用避孕套与感染人乳头瘤病毒的风险
N Engl J Med. 2006 Jun 22;354(25):2645-54. doi: 10.1056/NEJMoa053284.
4
Time to clearance of human papillomavirus infection by type and human immunodeficiency virus serostatus.按人乳头瘤病毒类型及人类免疫缺陷病毒血清学状态划分的人乳头瘤病毒感染清除时间
Int J Cancer. 2006 Oct 1;119(7):1623-9. doi: 10.1002/ijc.22015.
5
Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial.二价L1病毒样颗粒疫苗针对16型和18型人乳头瘤病毒长达4.5年的持续疗效：一项随机对照试验的随访结果
Lancet. 2006 Apr 15;367(9518):1247-55. doi: 10.1016/S0140-6736(06)68439-0.
6
The promise of the human papillomavirus vaccine does not confer immunity against ethical reflection.人乳头瘤病毒疫苗的前景并不能赋予针对伦理反思的免疫力。
Oncologist. 2006 Apr;11(4):393-6. doi: 10.1634/theoncologist.11-4-393.
7
Ethical analysis of HPV vaccine policy options.人乳头瘤病毒疫苗政策选择的伦理分析
Vaccine. 2006 May 29;24(22):4812-20. doi: 10.1016/j.vaccine.2006.03.019. Epub 2006 Mar 23.
8
Randomized controlled trial of Hepatitis B virus vaccine in HIV-1-infected patients comparing two different doses.比较两种不同剂量的乙肝病毒疫苗用于HIV-1感染患者的随机对照试验。
AIDS Res Ther. 2006 Apr 6;3:9. doi: 10.1186/1742-6405-3-9.
9
Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses.芬兰人乳头瘤病毒16型与宫颈癌的流行病学及疫苗接种的潜在影响：数学建模分析
PLoS Med. 2006 May;3(5):e138. doi: 10.1371/journal.pmed.0030138. Epub 2006 Apr 4.
10
The potential of human papillomavirus vaccines.人乳头瘤病毒疫苗的潜力。
N Engl J Med. 2006 Mar 16;354(11):1109-12. doi: 10.1056/NEJMp058305.
Zotero 插件